Product Information
INGREZZA 60 MG CAPSULE is a brand product labeled by Neurocrine Biosciences, Inc., priced at $283.3240 per EA under NDC 70370106001. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
60 mg/1
Manufacturer
Neurocrine Biosciences, Inc.NDC
70370106001
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VALBENAZINE TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA209241On Market Since
4/23/2021
Pharmacological Classes
Price Statistics
The NADAC for INGREZZA 60 MG CAPSULE has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $283.3240 per EA |
|---|---|
| All-time high | $283.3249 (May 13, 2026) |
| All-time low | $264.0367 (Apr 17, 2024) |
| 52-week high | $283.3249 |
| 52-week low | $274.5423 |
| Median price | $274.5426 |
| Average price | $274.8470 |
| Largest weekly change | +3.4% (Nov 27, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Valbenazine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of INGREZZA 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INGREZZA 60 MG CAPSULE, manufactured by Neurocrine Biosciences, Inc., is $283.3240 per EA (NDC 70370106001), effective Jun 24, 2026.
How has the price of INGREZZA 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INGREZZA 60 MG CAPSULE has risen 7.3%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for INGREZZA 60 MG CAPSULE?
Since Apr 17, 2024, the NADAC for INGREZZA 60 MG CAPSULE has ranged from a low of $264.0367 (Apr 17, 2024) to a high of $283.3249 (May 13, 2026), with a median of $274.5426 per EA.
Are there cheaper alternatives to INGREZZA 60 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of INGREZZA 60 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures INGREZZA 60 MG CAPSULE?
INGREZZA 60 MG CAPSULE (NDC 70370106001) is labeled by Neurocrine Biosciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification